BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2011
View Archived Issues
New tyrosine-protein kinase SYK inhibitors presented
Read More
New HIV-1 clade C consensus envelope sequence-based DNA vaccine is immunogenic in vivo
Read More
Novel imidazo[1,2-b]pyridazine derivative ameliorates symptoms of arthritis in vivo
Read More
New dipeptidyl peptidase 1 inhibitors claimed
Read More
Sanofi discloses novel pim inhibitors for cancer
Read More
Katholieke Universiteit Leuven describes new antifungal agents
Read More
Photocure begins enrollment in new phase II Visonac study
Read More
Merck & Co.'s new frizzled SMO receptor antagonist MK-5710 has antitumor activity in vivo
Read More
New MAP kinase-activated protein kinase 2 inhibitors discovered
Read More
PET tracer [18F]-MK-3328 shows favorable uptake in brain of patients with AD
Read More
Janssen Pharmaceuticals to divest U.S. Ortho Dermatologics division
Read More
FDA approves delayed-release mesalamine tablets for maintenance of remission of ulcerative colitis
Read More
COMP recommends orphan drug status for Nektar Therapeutics' lead oncology agent in ovarian cancer
Read More
Afexa Life Sciences clear to begin study of AFX-2 in patients with chronic lymphocytic leukemia
Read More
Cyclacel and Daiichi Sankyo amend sapacitabine licensing agreement
Read More
Daiichi Sankyo launches Lixiana in Japan
Read More
Nabi Biopharmaceuticals reports on first confirmatory phase III NicVAX study
Read More
Talon Therapeutics submits NDA for Marqibo to FDA
Read More
Dificid tablets launched in U.S. for CDI-associated diarrhea
Read More
Halaven launched in Japan for inoperable/recurrent breast cancer
Read More
Merck & Co. gains European approval for Victrelis
Read More
Japanese launch of Rivastach patch for Alzheimer's type-dementia
Read More
Chugai set to launch Mircera injection syringe in Japan for treatment of renal anemia
Read More
Phase III data presented on subcutaneous Actemra versus intravenous infusion
Read More
Upsher-Smith Laboratories initiates phase III trial of USL-261
Read More